Cargando…
RRM2‑mediated Wnt/β‑catenin signaling pathway activation in lung adenocarcinoma: A potential prognostic biomarker
The present study aimed to investigate the role and mechanism of action of ribonucleotide reductase M2 (RRM2) in lung adenocarcinoma and its potential as a therapeutic target. Data of patients with lung adenocarcinoma from The Cancer Genome Atlas database were collected and analyzed to evaluate the...
Autores principales: | Jiang, Yongjie, Hu, Xing, Pang, Min, Huang, Yuyan, Ren, Bi, He, Liping, Jiang, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472049/ https://www.ncbi.nlm.nih.gov/pubmed/37664657 http://dx.doi.org/10.3892/ol.2023.14003 |
Ejemplares similares
-
RRM2 regulates osteogenesis of mouse embryo fibroblasts via the Wnt/β‑catenin signaling pathway
por: Cai, Haijun, et al.
Publicado: (2022) -
Silencing RRM2 inhibits multiple myeloma by targeting the Wnt/β-catenin signaling pathway
por: Liu, Xia, et al.
Publicado: (2019) -
Independent prognostic implications of RRM2 in lung adenocarcinoma
por: Ma, Chao, et al.
Publicado: (2020) -
Chromobox 4 facilitates tumorigenesis of lung adenocarcinoma through the Wnt/β-catenin pathway
por: Wang, Zuoyun, et al.
Publicado: (2020) -
RFC3 induces epithelial-mesenchymal transition in lung adenocarcinoma cells through the Wnt/β-catenin pathway and possesses prognostic value in lung adenocarcinoma
por: Gong, Shulei, et al.
Publicado: (2019)